3 results
Approved WMOCompleted
The primary objective of this study is to evaluate if PVI performed with cryoballoon and other cryocatheters is superior to AAD as first-line therapy in preventing atrial arrhythmia recurrences
Approved WMORecruiting
The objective of this study is to support the pharma partner*s Phase III trial using Tina-quant Lipoprotein (a) RxDx assay for subject selection and optional batch testing of follow-up samples. This study is carried out to evaluate the performance…
Approved WMORecruiting
• To assess the tolerability and safety of the investigational medicinal product